CMCristiane Sampaio de Mara

Cristiane Sampaio de Mara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cristiane Sampaio de Mara has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • A. C. M. Luzo

    Laboratory of Molecular Biology of Cartilage, Division of Rheumatology, Department of Clinical Medicine, State University of Campinas, UNICAMP, Campinas, Brazil

    1 shared publication
  • A. R. Sartori-Cintra

    Laboratory of Molecular Biology of Cartilage, Division of Rheumatology, Department of Clinical Medicine, State University of Campinas, UNICAMP, Campinas, Brazil

    1 shared publication
  • A. S. S. Duarte

    Laboratory of Molecular Biology of Cartilage, Division of Rheumatology, Department of Clinical Medicine, State University of Campinas, UNICAMP, Campinas, Brazil

    1 shared publication
  • Adriana S.S. Duarte

    1 shared publication
  • Adriana Silva Duarte

    State University of Campinas

    1 shared publication
  • Andre Luis Lugani Andrade

    State University of Campinas

    1 shared publication

Latest Publications

  • Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6

    by Cristiane Sampaio de Mara, A. S. S. Duarte, A. R. Sartori-Cintra, A. C. M. Luzo, S T. O. Saad, I. B. Coimbra

    Umbilical cord blood contains undifferentiated mesenchymal stem cells (MSCs) with chondrogenic potential that may be used for the repair of joint damage. The role of growth factors during the process of chondrogenesis is still not entirely understood. The objective of this study was to evaluate the formation of chondrocytes, cartilaginous matrix and type II collagen from human umbilical cord blood stem cells exposed to two different growth factors, BMP-6 and BMP-2, while being cultured as a micromass or a monolayer. Umbilical cord blood was obtained from full-term deliveries, and then, mononuclear cells were separated and cultured for expansion. Afterward, these cells were evaluated by flow cytometry using antibodies specific for MSCs and induced to chondrogenic differentiation in micromass and monolayer cultures supplemented with BMP-2 and BMP-6. Cellular phenotype was evaluated after 7, 14 and 21 days by RT-PCR and Western blot analysis to identify the type II collagen and aggrecan. The expanded cells displayed surface antigens characteristic of mesenchymal progenitor cells and were negative for hematopoietic differentiation antigens. Type II collagen and aggrecan mRNAs were expressed from day 14 in cells stimulated with BMP-2 or BMP-6. Type II collagen was demonstrated by Western blotting in both groups, and the greatest expression was observed 21 days after the cells were stimulated with BMP-2 cultured in micromass. BMP-2 in micromass culture was more efficient to induce the chondrogenesis.


  • Open Access

    Periosteum as a source of mesenchymal stem cells: the effects of TGF-β3 on chondrogenesis

    by Cristiane Sampaio de Mara, Angélica Rossi Sartori, Adriana Silva Duarte, Andre Luis Lugani Andrade, Marcio Amaral Camargo Pedro, Ibsen Bellini Coimbra


  • Regulation of Chondrogenesis by Transforming Growth Factor-ß3 and Insulin-like Growth Factor-1 from Human Mesenchymal Umbilical Cord Blood Cells

    by Cristiane S. Mara, Adriana S.S. Duarte, Angelica Sartori, Angela C. Luzo, Sara T.O. Saad, Ibsen B. Coimbra

    Objective. Mature articular cartilage is vulnerable to injuries and disease processes that cause irreversible tissue damage because of its limited capacity for self-repair. Umbilical cord blood is a source of mesenchymal stem cells, which can give rise to cells of different lineages, including cartilage, bone, and fat. Cellular condensation is a required step in the initiation of mesenchymal chondrogenesis. We attempted to differentiate cells from umbilical cord blood into chondrocytes with insulin-like growth factor 1 (IGF-1) and transforming growth factor-ß3 (TGF-ß3). Methods. Cells were grown in high density micromass and monolayer culture systems and then evaluated for expression of type II collagen, aggrecan, and Sox9. Umbilical cord blood from 130 patients was harvested. Results. Expression of type II collagen, aggrecan, and Sox9 was detected after 14 days in TGF-ß3- and IGF-1-stimulated cells in both types of culture (monolayer and micromass). On Day 21 in the micromass culture, expression levels were greater than they were at 14 days for all genes. TGF-ß3 was found to be more efficient at promoting chondrogenesis than IGF-1. By western blot, we also found that after 3 weeks, the expression of type II collagen was greater in micromass culture with TGF-ß3. Conclusion. TGF-ß3 used in micromass culture is the best growth factor for promoting the proliferation and differentiation of mesenchymal cells from umbilical cord blood during chondrogenesis. This approach may provide an alternative to autologous grafting.